Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.30 USD
Change Today 0.00 / 0.00%
Volume 11.0K
As of 9:32 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

P. Ron Ellis

Co-Founder, Chief Executive Officer, President and Director,Endocyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. P. Ron Ellis is a Co-Founder of Endocyte, Inc. and has been its Chief Executive Officer and President since January 1996. Mr. Ellis joined Endocyte, Inc. in January 1996. Mr. Ellis has over 18 years of health care and biotechnology experience. He served as Vice President of Hill-Rom. While at Hill-Rom, he served in a variety of positions in marketing, product development, mergers/acquisitions, business development, corporate strategy and general management. Mr. Ellis ...

Read Full Background

Corporate Headquarters*

3000 Kent Avenue
West Lafayette, Indiana 47906

United States

Phone: 765-463-7175
Fax: 765-463-9271

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director


Brigham Young University
Brigham Young University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$475,612

Stock Options*

Restricted Stock Awards$249,975
All Other Compensation$8,640
Exercised Options99,060
Exercised Options Value$1,034,234
Exercisable Options630,218
Exercisable Options Value$1,410,780
Unexercisable Options440,000
Unexercisable Options Value$274,000
Total Value of Options$2,719,013
Total Number of Options1,169,278

Total Compensation*

Total Annual Cash Compensation$707,076
Total Short Term Compensation$475,612
Other Long Term Compensation$258,615
Total Calculated Compensation$2,171,241
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECYT:US $5.30 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDOCYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at